Table 3 Impact of MDTMs on quality of care
Overall | Colon | Rectum | ||||
|---|---|---|---|---|---|---|
Metastatic | n = 1090 | n = 816 | n = 274 | |||
Chemotherapy | No | Yes | No | Yes | No | Yes |
374 (34) | 716 (66) | 306 (38) | 510 (62) | 68 (25) | 206 (75) | |
Presentation in MDTMs | p < 0.001 | p < 0.001 | p < 0.001a | |||
Yes | 268 (28) | 673 (72) | 214 (31) | 475 (69) | 54 (21) | 198 (79) |
No | 39 (91) | 4 (9) | 34 (92) | 3 (8) | 5 (83) | 1 (17) |
Unknown | 67 (63) | 39 (37) | 58 (64) | 32 (36) | 9 (56) | 7 (44) |
Non-metastatic N+ | n = 806 | n = 608 | n = 198 | |||
Adjuvant chemotherapy | No | Yes | No | Yes | No | Yes |
252 (31) | 554 (69) | 220 (36) | 388 (64) | 32 (16) | 166 (84) | |
Presentation in MDTMs | p < 0.001 | p < 0.001 | p = 1a | |||
Yes | 209 (29) | 515 (71) | 178 (33) | 359 (67) | 31 (17) | 156 (83) |
No | 15 (100) | 0 | 15 (100) | 0 | na | na |
Unknown | 28 (42) | 39 (55) | 27 (48) | 29 (52) | 1 (9) | 11 (91) |
Locally advanced | n = 259 | |||||
Pre-operative chemoradiotherapy | No | Yes | ||||
70 (27) | 189 (73) | |||||
Presentation in MDTMs | p = 0.5a | |||||
Yes | 66 (27) | 182 (73) | ||||
No | na | na | ||||
Unknown | 4 (36) | 7 (64) | ||||